Hi there! I’m Caitlin, the Marketing and Communications Manager here at My Gene Counsel. One year ago this month, I was diagnosed with breast cancer at age 33. The irony is not lost on me that my job at a healthcare tech startup focused on accurate and timely...
In 2019, the field of personalized medicine continued to grow with the market launch of more than two dozen drugs targeting novel genomic alterations and numerous genetic tests to determine whether patients are at risk for serious diseases like cancer, and whether...
Investigators at Ambry Genetics, the Mayo Clinic in Rochester, the University of Utah, and the University of California at Irvine have tapped into Ambry’s large collection of multigene panel test results to clarify hereditary cancer associations in high-risk...
The National Comprehensive Cancer Network (NCCN) provides guidelines to help determine who should have genetic testing for hereditary cancers and how individuals should be followed after testing. They recently published updates to these guidelines that we’ve...
